Home R&D Page 7

R&D

Good results for a phase I/II head and neck cancer trial

Results of the antibiotic cadazolid

Chinese cell therapy effective in small multiple myeloma trial

New vaccine to protect adolescent and adult from Men B

Exceptional curcumstances approval for dinutuximab beta in neuroblastoma

Pierluigi Petrone: the first European in the Global Virus Network Board

Positive interim results for emicizumab in phase III study of children...

Phase 2 Trial of Tarextumab in Small Cell Lung Cancer Does...

Evolocumab: lowering LDL-C to unprecedented levels did not negatively impact cognition

EMA approved tofacitinib for moderate to severe rheumatoid arthritis

1...678...17Page 7 of 17
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151